Insider filing · NBIX
Ingrid Delaet
Chief Regulatory Officer
profile →
Neurocrine Biosciences, Inc.
NBIX · Healthcare · 59 filings in 24 months
ticker →
Ingrid Delaet sold $354K of Neurocrine Biosciences (NBIX)
Executed May 29, disclosed Jun 2, 4 days later.
Value, as filed
$354K
2,261 sh × $156.71
Executed
May 29
the trade date, as filed
Disclosed
Jun 2
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
IDIngrid Delaet (Chief Regulatory Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $2.6M of NBIX (14,571 sh across 3 lots, as filed), executed Jul 7.
The name
NBIXHealthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Ingrid Delaet in NBIX
NBIXSALE
Neurocrine Biosciences, Inc.
$791K4,367 sh × $181.02
Exec Jul 10
Filed Jul 13 · 4:27 PM ET NBIXSALE Neurocrine Biosciences, Inc. $2.6M
14,571 sh across 3 lots
Exec Jul 7
Filed Jul 9 · 6:41 PM ET NBIXSALE Neurocrine Biosciences, Inc. $147K
1,091 sh × $135.00
Exec Dec 17 2024
Filed Dec 19 2024 · 5:30 PM ET